Stocktwits on MSN
MNPR stock rallies after hours as experimental drug shows rapid copper balance improvement in genetic disorder
Last week, the company said that it plans to file a New Drug Application with the U.S. Food and Drug Administration in ...
Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today ...
Copper-Loaded Scaffolds for Targeted Treatment of Traumatic Brain Injury. This illustration shows the process of electrospinning copper oxide-loaded polycaprolactone (PCL) and gelatin (Gel) scaffolds ...
WILMETTE, Ill., Nov. 09, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, ...
Studies in the roundworm model organism Caenorhabditis elegans, headed by scientists at Florida Atlantic University’s Schmidt College of Medicine and FAU Stiles-Nicholson Brain Institute, have ...
In studies of mouse cells, researchers have found that low levels of cellular copper appear to make fat cells fatter by altering how cells process their main metabolic fuels, such as fat and sugar. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results